Selected research
Market Structure
Global Plasma Fractionation Technology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Plasma Fractionation Technology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Plasma Fractionation Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Plasma Fractionation Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Plasma Fractionation Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Plasma Fractionation Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Plasma Fractionation Technology include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Plasma Fractionation Technology market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Plasma Fractionation Technology and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Plasma Fractionation Technology revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Plasma Fractionation Technology market size, projected growth trends, production technologies, key applications, and end-use industries.
Plasma Fractionation Technology Segment by Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Plasma Fractionation Technology Segment by Type
Immune Globulin
Coagulation Factor
Albumin
Other
Plasma Fractionation Technology Segment by Application
Hospital
Retail Pharmacy
Other
Plasma Fractionation Technology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Fractionation Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma Fractionation Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Fractionation Technology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Plasma Fractionation Technology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plasma Fractionation Technology industry.
Chapter 3: Detailed analysis of Plasma Fractionation Technology companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasma Fractionation Technologyrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Immune Globulin
- Coagulation Factor
- Albumin
- Other
Applications
- Hospital
- Retail Pharmacy
- Other
Companies covered
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Plasma Fractionation Technology Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Immune Globulin
- 1.2.3 Coagulation Factor
- 1.2.4 Albumin
- 1.2.5 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global Plasma Fractionation Technology Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Retail Pharmacy
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Plasma Fractionation Technology Growth Trends by Region
- 1.5.1 Global Plasma Fractionation Technology Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Plasma Fractionation Technology Market Size by Region (2021-2026)
- 1.5.3 Plasma Fractionation Technology Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Plasma Fractionation Technology Market Dynamics
- 2.1 Plasma Fractionation Technology Industry Trends
- 2.2 Plasma Fractionation Technology Industry Drivers
- 2.3 Plasma Fractionation Technology Industry Opportunities and Challenges
- 2.4 Plasma Fractionation Technology Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Plasma Fractionation Technology Revenue by Company (2021-2026)
- 3.2 Global Plasma Fractionation Technology Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Plasma Fractionation Technology Key Company Head office and Area Served
- 3.4 Global Plasma Fractionation Technology Company, Product Type & Application
- 3.5 Global Plasma Fractionation Technology Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Plasma Fractionation Technology Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Plasma Fractionation Technology Players Market Share by Revenue in 2025
- 3.6.3 2025 Plasma Fractionation Technology Tier 1, Tier 2, and Tier 3
4 Plasma Fractionation Technology Market by Type
- 4.1 Global Plasma Fractionation Technology Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Plasma Fractionation Technology Market Size by Type (2021-2032)
- 4.3 Global Plasma Fractionation Technology Market Size Share by Type (2021-2032)
5 Plasma Fractionation Technology Market by Application
- 5.1 Global Plasma Fractionation Technology Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Plasma Fractionation Technology Market Size by Application (2021-2032)
- 5.3 Global Plasma Fractionation Technology Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Takeda
- 6.1.1 Takeda Company Information
- 6.1.2 Takeda Business Overview
- 6.1.3 Takeda Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Takeda Plasma Fractionation Technology Product Portfolio
- 6.1.5 Takeda Recent Developments
- 6.2 CSL
- 6.2.1 CSL Company Information
- 6.2.2 CSL Business Overview
- 6.2.3 CSL Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 CSL Plasma Fractionation Technology Product Portfolio
- 6.2.5 CSL Recent Developments
- 6.3 Grifols
- 6.3.1 Grifols Company Information
- 6.3.2 Grifols Business Overview
- 6.3.3 Grifols Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Grifols Plasma Fractionation Technology Product Portfolio
- 6.3.5 Grifols Recent Developments
- 6.4 Octapharma
- 6.4.1 Octapharma Company Information
- 6.4.2 Octapharma Business Overview
- 6.4.3 Octapharma Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Octapharma Plasma Fractionation Technology Product Portfolio
- 6.4.5 Octapharma Recent Developments
- 6.5 Kedrion
- 6.5.1 Kedrion Company Information
- 6.5.2 Kedrion Business Overview
- 6.5.3 Kedrion Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Kedrion Plasma Fractionation Technology Product Portfolio
- 6.5.5 Kedrion Recent Developments
- 6.6 LFB Group
- 6.6.1 LFB Group Company Information
- 6.6.2 LFB Group Business Overview
- 6.6.3 LFB Group Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 LFB Group Plasma Fractionation Technology Product Portfolio
- 6.6.5 LFB Group Recent Developments
- 6.7 Biotest
- 6.7.1 Biotest Company Information
- 6.7.2 Biotest Business Overview
- 6.7.3 Biotest Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Biotest Plasma Fractionation Technology Product Portfolio
- 6.7.5 Biotest Recent Developments
- 6.8 BPL
- 6.8.1 BPL Company Information
- 6.8.2 BPL Business Overview
- 6.8.3 BPL Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 BPL Plasma Fractionation Technology Product Portfolio
- 6.8.5 BPL Recent Developments
- 6.9 RAAS
- 6.9.1 RAAS Company Information
- 6.9.2 RAAS Business Overview
- 6.9.3 RAAS Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 RAAS Plasma Fractionation Technology Product Portfolio
- 6.9.5 RAAS Recent Developments
- 6.10 CBPO
- 6.10.1 CBPO Company Information
- 6.10.2 CBPO Business Overview
- 6.10.3 CBPO Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 CBPO Plasma Fractionation Technology Product Portfolio
- 6.10.5 CBPO Recent Developments
- 6.11 Hualan Bio
- 6.11.1 Hualan Bio Company Information
- 6.11.2 Hualan Bio Business Overview
- 6.11.3 Hualan Bio Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Hualan Bio Plasma Fractionation Technology Product Portfolio
- 6.11.5 Hualan Bio Recent Developments
- 6.12 Tiantan Bio
- 6.12.1 Tiantan Bio Company Information
- 6.12.2 Tiantan Bio Business Overview
- 6.12.3 Tiantan Bio Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Tiantan Bio Plasma Fractionation Technology Product Portfolio
- 6.12.5 Tiantan Bio Recent Developments
- 6.13 Shuanglin Bio
- 6.13.1 Shuanglin Bio Company Information
- 6.13.2 Shuanglin Bio Business Overview
- 6.13.3 Shuanglin Bio Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Shuanglin Bio Plasma Fractionation Technology Product Portfolio
- 6.13.5 Shuanglin Bio Recent Developments
- 6.14 Boya Bio
- 6.14.1 Boya Bio Company Information
- 6.14.2 Boya Bio Business Overview
- 6.14.3 Boya Bio Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Boya Bio Plasma Fractionation Technology Product Portfolio
- 6.14.5 Boya Bio Recent Developments
- 6.15 Yuanda Shuyang
- 6.15.1 Yuanda Shuyang Company Information
- 6.15.2 Yuanda Shuyang Business Overview
- 6.15.3 Yuanda Shuyang Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Yuanda Shuyang Plasma Fractionation Technology Product Portfolio
- 6.15.5 Yuanda Shuyang Recent Developments
- 6.16 Weiguang Bio
- 6.16.1 Weiguang Bio Company Information
- 6.16.2 Weiguang Bio Business Overview
- 6.16.3 Weiguang Bio Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Weiguang Bio Plasma Fractionation Technology Product Portfolio
- 6.16.5 Weiguang Bio Recent Developments
- 6.17 Nanyue Bio
- 6.17.1 Nanyue Bio Company Information
- 6.17.2 Nanyue Bio Business Overview
- 6.17.3 Nanyue Bio Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Nanyue Bio Plasma Fractionation Technology Product Portfolio
- 6.17.5 Nanyue Bio Recent Developments
- 6.18 KM Biologics
- 6.18.1 KM Biologics Company Information
- 6.18.2 KM Biologics Business Overview
- 6.18.3 KM Biologics Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 KM Biologics Plasma Fractionation Technology Product Portfolio
- 6.18.5 KM Biologics Recent Developments
7 North America
- 7.1 North America Plasma Fractionation Technology Market Size (2021-2032)
- 7.2 North America Plasma Fractionation Technology Market Size by Type
- 7.2.1 North America Plasma Fractionation Technology Market Size by Type (2021-2026)
- 7.2.2 North America Plasma Fractionation Technology Market Size by Type (2027-2032)
- 7.2.3 North America Plasma Fractionation Technology Market Share by Type (2021-2032)
- 7.3 North America Plasma Fractionation Technology Market Size by Application
- 7.3.1 North America Plasma Fractionation Technology Market Size by Application (2021-2026)
- 7.3.2 North America Plasma Fractionation Technology Market Size by Application (2027-2032)
- 7.3.3 North America Plasma Fractionation Technology Market Share by Application (2021-2032)
- 7.4 North America Plasma Fractionation Technology Market Size by Country
- 7.4.1 North America Plasma Fractionation Technology Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Plasma Fractionation Technology Market Size by Country (2021-2026)
- 7.4.3 North America Plasma Fractionation Technology Market Size by Country (2027-2032)
- 7.4.4 North America Plasma Fractionation Technology Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Plasma Fractionation Technology Market Size (2021-2032)
- 8.2 Europe Plasma Fractionation Technology Market Size by Type
- 8.2.1 Europe Plasma Fractionation Technology Market Size by Type (2021-2026)
- 8.2.2 Europe Plasma Fractionation Technology Market Size by Type (2027-2032)
- 8.2.3 Europe Plasma Fractionation Technology Market Share by Type (2021-2032)
- 8.3 Europe Plasma Fractionation Technology Market Size by Application
- 8.3.1 Europe Plasma Fractionation Technology Market Size by Application (2021-2026)
- 8.3.2 Europe Plasma Fractionation Technology Market Size by Application (2027-2032)
- 8.3.3 Europe Plasma Fractionation Technology Market Share by Application (2021-2032)
- 8.4 Europe Plasma Fractionation Technology Market Size by Country
- 8.4.1 Europe Plasma Fractionation Technology Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Plasma Fractionation Technology Market Size by Country (2021-2026)
- 8.4.3 Europe Plasma Fractionation Technology Market Size by Country (2027-2032)
- 8.4.4 Europe Plasma Fractionation Technology Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Plasma Fractionation Technology Market Size (2021-2032)
- 9.2 China Plasma Fractionation Technology Market Size by Type
- 9.2.1 China Plasma Fractionation Technology Market Size by Type (2021-2026)
- 9.2.2 China Plasma Fractionation Technology Market Size by Type (2027-2032)
- 9.2.3 China Plasma Fractionation Technology Market Share by Type (2021-2032)
- 9.3 China Plasma Fractionation Technology Market Size by Application
- 9.3.1 China Plasma Fractionation Technology Market Size by Application (2021-2026)
- 9.3.2 China Plasma Fractionation Technology Market Size by Application (2027-2032)
- 9.3.3 China Plasma Fractionation Technology Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Plasma Fractionation Technology Market Size (2021-2032)
- 10.2 Asia Plasma Fractionation Technology Market Size by Type
- 10.2.1 Asia Plasma Fractionation Technology Market Size by Type (2021-2026)
- 10.2.2 Asia Plasma Fractionation Technology Market Size by Type (2027-2032)
- 10.2.3 Asia Plasma Fractionation Technology Market Share by Type (2021-2032)
- 10.3 Asia Plasma Fractionation Technology Market Size by Application
- 10.3.1 Asia Plasma Fractionation Technology Market Size by Application (2021-2026)
- 10.3.2 Asia Plasma Fractionation Technology Market Size by Application (2027-2032)
- 10.3.3 Asia Plasma Fractionation Technology Market Share by Application (2021-2032)
- 10.4 Asia Plasma Fractionation Technology Market Size by Country
- 10.4.1 Asia Plasma Fractionation Technology Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Plasma Fractionation Technology Market Size by Country (2021-2026)
- 10.4.3 Asia Plasma Fractionation Technology Market Size by Country (2027-2032)
- 10.4.4 Asia Plasma Fractionation Technology Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Plasma Fractionation Technology Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Plasma Fractionation Technology Market Size by Type
- 11.2.1 South America, Middle East & Africa Plasma Fractionation Technology Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Plasma Fractionation Technology Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Plasma Fractionation Technology Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Plasma Fractionation Technology Market Size by Application
- 11.3.1 South America, Middle East & Africa Plasma Fractionation Technology Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Plasma Fractionation Technology Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Plasma Fractionation Technology Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Plasma Fractionation Technology Market Size by Country
- 11.4.1 South America, Middle East & Africa Plasma Fractionation Technology Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Plasma Fractionation Technology Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Plasma Fractionation Technology Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Plasma Fractionation Technology Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst